You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage
Alexander Y. Zubkov; Jayawant N. Mandrekar; Daniel O. Claassen; Edward M. Manno; Eelco F. M. Wijdicks; Alejandro A. Rabinstein
Arch Neurol 2008; 65: 1320-1325.
[Abstract][Full text][PDF]
Original Contributions Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease: An Open-Label Polysomnographic Study
William G. Ondo; Thomas Perkins; Todd Swick; Keith L. Hull Jr; J. Ernesto Jimenez; Tippy S. Garris; Daniel Pardi
Arch Neurol 2008; 65: 1337-1340.
[Abstract][Full text][PDF]
Original Contributions A Magnetic Resonance Imaging Voxel-Based Morphometry Study of Regional Gray Matter Atrophy in Patients With Benign Multiple Sclerosis
Clinical Trials Phase 2 Safety Trial Targeting Amyloid β Production With a -Secretase Inhibitor in Alzheimer Disease
Adam S. Fleisher; Rema Raman; Eric R. Siemers; Lida Becerra; Christopher M. Clark; Robert A. Dean; Martin R. Farlow; James E. Galvin; Elaine R. Peskind; Joseph F. Quinn; Abdullah Sherzai; B. Brooke Sowell; Paul S. Aisen; Leon J. Thal
Arch Neurol 2008; 65: 1031-1038.
[Abstract][Full text][PDF]
Original Contributions Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Chitra Krishnan; Adam I. Kaplin; Robert A. Brodsky; Daniel B. Drachman; Richard J. Jones; Dzung L. Pham; Nancy D. Richert; Carlos A. Pardo; David M. Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C. McArthur; Avindra Nath; Benjamin M. Greenberg; Peter A. Calabresi; Douglas A. Kerr
Arch Neurol 2008; 65: 1044-1051.
[Abstract][Full text][PDF]
Editorials Abeta Predictor of Alzheimer Disease Symptoms
Clinical Trials Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib